BioSig Technologies clarified that its merger with Streamex Exchange Corporation remains unaffected, with the merger already closed on May 28, 2025. The company will adjourn Proposal No. 1 pending NASDAQ approval, but this does not impact the merger, financings, or company operations.

Smartkem has hired Anthony Amato and his consulting firm Bridge Associates International Pharmaceutical Consulting (BAIPC) to provide strategic advisory services and support the company's long-term growth initiatives in semiconductor technology.

BioSig Technologies completed a public offering of 3,852,149 shares at $3.90 per share, raising approximately $15 million to support gold tokenization infrastructure and corporate operations.

BioSig Technologies announced a public offering of 3,852,149 shares at $3.90 per share, expecting to raise approximately $15 million. The company plans to use proceeds for gold bullion purchase, working capital, and general corporate purposes.

BioSig Technologies plans to convert $1.1 billion in physical gold bullion into crypto tokens on the Solana blockchain, potentially tripling the value of real-world assets on the network and signaling a significant move in commodity tokenization.